ProShare Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2M Buy
26,138
+2,238
+9% +$946K 0.01% 367
2026
Q1
$11.3M Sell
23,900
-6,503
-21% -$3.27M 0.02% 339
2025
Q4
$14.2M Buy
30,403
+1,755
+6% +$815K 0.03% 309
2025
Q3
$12.2M Sell
28,648
-2,196
-7% -$851K 0.03% 327
2025
Q2
$11.8M Buy
30,844
+1,960
+7% +$706K 0.02% 320
2025
Q1
$9.98M Sell
28,884
-883
-3% -$284K 0.02% 333
2024
Q4
$8.93M Buy
29,767
+2,583
+10% +$903K 0.02% 342
2024
Q3
$11M Sell
27,184
-3,045
-10% -$1.11M 0.03% 321
2024
Q2
$9.71M Buy
30,229
+1,433
+5% +$466K 0.03% 328
2024
Q1
$9.6M Sell
28,796
-2,284
-7% -$698K 0.03% 319
2023
Q4
$8.41M Sell
31,080
-3,051
-9% -$754K 0.03% 384
2023
Q3
$8.4M Sell
34,131
-300
-0.9% -$82.1K 0.03% 328
2023
Q2
$10.4M Buy
34,431
+1,667
+5% +$463K 0.03% 298
2023
Q1
$8.64M Buy
32,764
+2,074
+7% +$527K 0.03% 372
2022
Q4
$7.36M Sell
30,690
-2,143
-7% -$480K 0.03% 387
2022
Q3
$6.03M Sell
32,833
-5,200
-14% -$1.04M 0.02% 420
2022
Q2
$6.39M Sell
38,033
-19,377
-34% -$4.16M 0.02% 434
2022
Q1
$14.4M Sell
57,410
-1,452
-2% -$365K 0.03% 296
2021
Q4
$15.1M Buy
58,862
+10,528
+22% +$2.58M 0.03% 294
2021
Q3
$11.7M Sell
48,334
-3,974
-8% -$972K 0.03% 314
2021
Q2
$10.8M Buy
52,308
+6,983
+15% +$1.42M 0.03% 344
2021
Q1
$8.54M Buy
45,325
+1,742
+4% +$307K 0.03% 392
2020
Q4
$7.17M Buy
43,583
+3,375
+8% +$493K 0.03% 391
2020
Q3
$5.01M Buy
40,208
+921
+2% +$114K 0.02% 401
2020
Q2
$3.81M Buy
39,287
+426
+1% +$44.3K 0.02% 437
2020
Q1
$3.49M Sell
38,861
-21,387
-35% -$2.77M 0.03% 386
2019
Q4
$8.9M Buy
60,248
+8,797
+17% +$1.18M 0.04% 352
2019
Q3
$6.2M Sell
51,451
-7,978
-13% -$1.03M 0.03% 386
2019
Q2
$8.03M Sell
59,429
-7,150
-11% -$904K 0.05% 342
2019
Q1
$8.68M Buy
66,579
+26,468
+66% +$3.55M 0.05% 329
2018
Q4
$4.99M Buy
40,111
+2,256
+6% +$303K 0.03% 390
2018
Q3
$5.27M Sell
37,855
-4,906
-11% -$611K 0.04% 410
2018
Q2
$4.39M Sell
42,761
-3,184
-7% -$322K 0.03% 462
2018
Q1
$4.46M Buy
45,945
+522
+1% +$50.6K 0.03% 459
2017
Q4
$3.99M Sell
45,423
-8,993
-17% -$722K 0.03% 469
2017
Q3
$4.33M Buy
54,416
+4,476
+9% +$360K 0.04% 399
2017
Q2
$4.36M Sell
49,940
-501
-1% -$42.4K 0.04% 378
2017
Q1
$4.49M Buy
50,441
+498
+1% +$41.5K 0.05% 367
2016
Q4
$3.7M Buy
49,943
+10,362
+26% +$776K 0.04% 393
2016
Q3
$2.99M Sell
39,581
-12,797
-24% -$980K 0.04% 372
2016
Q2
$4.03M Sell
52,378
-263
-0.5% -$20.8K 0.05% 285
2016
Q1
$4.11M Sell
52,641
-23,434
-31% -$1.64M 0.06% 273
2015
Q4
$5.14M Buy
76,075
+1,341
+2% +$93.5K 0.06% 279
2015
Q3
$5.78M Buy
74,734
+2,646
+4% +$234K 0.08% 248
2015
Q2
$6.54M Sell
72,088
-14,856
-17% -$1.19M 0.09% 222
2015
Q1
$6.54M Buy
86,944
+62,816
+260% +$4.51M 0.08% 263
2014
Q4
$1.77M Buy
24,128
+5,858
+32% +$412K 0.02% 603
2014
Q3
$1.29M Sell
18,270
-2,957
-14% -$195K 0.02% 971
2014
Q2
$1.2M Buy
21,227
+2,722
+15% +$144K 0.02% 1077
2014
Q1
$972K Buy
18,505
+1,522
+9% +$75.7K 0.01% 1323
2013
Q4
$810K Buy
16,983
+301
+2% +$13.9K 0.01% 1005
2013
Q3
$713K Buy
16,682
+8,279
+99% +$323K 0.02% 1146
2013
Q2
$303K Buy
+8,403
New +$325K 0.01% 1720

Other funds holding HCA

ProShare Advisors's HCA Position: Q2 2026 in Review

ProShare Advisors increased its HCA Healthcare (HCA) stake by 9.4% in Q2 2026, buying an estimated $946K and bringing the position to 26,138 shares worth $10.2M. The position accounts for 0.01% of the portfolio, ranked #367.

ProShare Advisors first reported a position in HCA in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.1M in Q4 2021. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • ProShare Advisors held 26,138 shares of HCA Healthcare worth $10.2M as of Q2 2026.
  • ProShare Advisors bought 2,238 HCA Healthcare shares in Q2 2026, an estimated $946K.
  • HCA Healthcare made up 0.01% of ProShare Advisors's portfolio in Q2 2026, its #367 holding.
  • ProShare Advisors first reported a position in HCA Healthcare in Q2 2013 and has held it in 53 quarters since.
  • ProShare Advisors's HCA Healthcare position peaked at $15.1M in Q4 2021.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.